法里西马布在两种不同类型的聚烯注射器中复合和储存后保持了物质的完整性和无菌性
Alexander Taschauer1,2, Arthur Sedivy3, Daniel Egger2,4
1Pharmacy of the University Hospital St. Pölten, St. Pölten, Austria.
Eye (London, England)
|December 5, 2024
概括
在注射器中使用内法里西马布 (一种双特异性抗VEGF/Ang-2生物药物) 的化合物最多可安全使用28天. 保持了化学,物理和微生物学稳定性,确保了临床使用的药物安全性.
科学领域:
- 眼科医生 眼科 眼科
- 药理学 药理学是指药理学的学科.
- 生物技术是生物技术.
背景情况:
- 内抗VEGF药物往往是复合的,并且在注射器中非标签存储.
- 在储存期间确保化合物完整性和微生物安全性至关重要.
- 法里西马布是一种新型双特异生物向VEGF和Ang-2的药物.
研究的目的:
- 评估法里西马布在聚烯注射器中复合和储存后的化学和物理稳定性.
- 评估复合法里西马布的微生物安全性 (无菌性,内毒素).
- 为了确定法里西马布与VEGF和Ang-2储存后的结合亲和力.
主要方法:
- 法里西马布被复合成两种类型的聚烯注射器 (无油和含油).
- 样品在2-8°C的温度下保存,保护免受光线照射,长达28天.
- 通过染色学,热度计,光谱学和光散射来评估稳定性;通过干扰计测量结合亲和力;测试了无菌性和内毒素水平.
主要成果:
- 在存储28天后,在任何一种注射器类型中都没有观察到VEGF和Ang-2结合亲和力的显著变化.
- 在整个储存期间,法里西马布的化学和物理稳定性保持一致.
- 保持了无菌性,并且在存储的样本中没有检测到细菌内毒素.
结论:
- 复合法里西马布在聚烯注射器中储存长达28天时显示出药物安全性.
- 这一发现支持了法里西马布在临床实践中具有成本效益的非标签用途的潜力.
- 该研究证实了在患者治疗中使用复合法里西马布的安全性.
更多相关视频
相关概念视频
01:22Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
01:19Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...
01:21Drug Accumulation During Multiple Dosing: Repetitive IV Injections
Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:28Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices
Parenteral drug delivery systems play a crucial role in modern therapeutics by enabling the direct administration of drugs into the systemic circulation, bypassing the gastrointestinal tract. These systems are particularly valuable for poorly absorbed oral medications that are unstable in the digestive environment or require rapid onset or sustained therapeutic levels. Delivery is achieved through intravenous, intramuscular, or subcutaneous routes, each selected based on the drug's properties...
01:21Intrauterine Drug Delivery Systems
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...